RxSight, Inc. (RXST)

NASDAQ: RXST · Real-Time Price · USD
8.96
-0.12 (-1.32%)
At close: Sep 17, 2025, 4:00 PM EDT
9.13
+0.17 (1.90%)
After-hours: Sep 17, 2025, 4:18 PM EDT
-1.32%
Market Cap366.61M
Revenue (ttm)147.06M
Net Income (ttm)-32.25M
Shares Out 40.92M
EPS (ttm)-0.80
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume676,276
Open9.10
Previous Close9.08
Day's Range8.84 - 9.40
52-Week Range6.32 - 57.53
Beta1.17
AnalystsHold
Price Target11.80 (+31.7%)
Earnings DateNov 6, 2025

About RXST

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company’s RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be... [Read more]

Sector Healthcare
IPO Date Jul 30, 2021
Employees 498
Stock Exchange NASDAQ
Ticker Symbol RXST
Full Company Profile

Financial Performance

In 2024, RxSight's revenue was $139.93 million, an increase of 57.09% compared to the previous year's $89.08 million. Losses were -$27.46 million, -43.52% less than in 2023.

Financial Statements

Analyst Summary

According to 11 analysts, the average rating for RXST stock is "Hold." The 12-month stock price target is $11.8, which is an increase of 31.70% from the latest price.

Price Target
$11.8
(31.70% upside)
Analyst Consensus: Hold
Stock Forecasts

News

DEADLINE NEXT WEEK: Berger Montague Advises RxSight, Inc. (NASDAQ: RXST) Investors to Contact the Firm Before September 22, 2025

PHILADELPHIA, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC, a nationally recognized securities litigation law firm, is investigating potential securities law violations involving RxSight, Inc...

1 day ago - GlobeNewsWire

RxSight, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - RXST

LOS ANGELES , Sept. 15, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of RxSight, Inc. ("RxSight" or "the Company") (NASDAQ: RXST) for violati...

2 days ago - PRNewsWire

RXST STOCK NEWS: RxSight, Inc. Investors Urged to Act by September 22 Court Deadline -- Contact BFA Law if You Suffered Losses

NEW YORK, Sept. 14, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against RxSight, Inc. (NASDAQ: RXST) and certain of the Comp...

3 days ago - GlobeNewsWire

RXST SECURITIES NOTICE: Did RxSight, Inc. Mislead Investors? Contact BFA Law if You Lost Money on Your Investment

NEW YORK, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against RxSight, Inc. (NASDAQ: RXST) and certain of the Comp...

5 days ago - GlobeNewsWire

RxSight, Inc. (RXST) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

RxSight, Inc. (NASDAQ:RXST) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 10:45 AM EDT Company Participants Ronald Kurtz - Co-President, CEO & Director Shelley Thunen - Co...

9 days ago - Seeking Alpha

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In RxSight To Contact Him Directly To Discuss Their Options If you purchased or acquired...

11 days ago - PRNewsWire

RXST LAWSUIT NOTICE: Lose Money on RxSight, Inc.? Contact BFA Law Prior to September 22 Legal Deadline (NASDAQ:RXST)

NEW YORK, Sept. 06, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against RxSight, Inc. (NASDAQ: RXST) and certain of the Comp...

11 days ago - GlobeNewsWire

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in RxSight, Inc. Lawsuit - RXST

NEW YORK , Sept. 4, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of RxSight, Inc. (NASDAQ: RXST).

13 days ago - PRNewsWire

RXST SHAREHOLDERS: RxSight, Inc. Investors may have been Affected by Fraud – Contact BFA Law by September 22 Court Deadline (NASDAQ:RXST)

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against RxSight, Inc. (NASDAQ: RXST) and certain of the Compa...

19 days ago - GlobeNewsWire

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In RxSight To Contact Him Directly To Discuss Their Options

19 days ago - GlobeNewsWire

RxSight, Inc. to Present at the Morgan Stanley Healthcare Conference

ALISO VIEJO, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following ca...

23 days ago - GlobeNewsWire

RXST CLASS REMINDER: Suffer Losses on Your RxSight, Inc. Investment? Contact BFA Law before the September 22 Court Deadline (NASDAQ:RXST)

NEW YORK, Aug. 23, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against RxSight, Inc. (NASDAQ: RXST) and certain of the Compa...

25 days ago - GlobeNewsWire

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In RxSight To Contact Him Directly To Discuss Their Options

26 days ago - GlobeNewsWire

Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd

NEW YORK , Aug. 21, 2025 /PRNewswire/ --  Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed on behalf of all persons or entities who purchased t...

27 days ago - PRNewsWire

RXSIGHT STOCK: Lose Money on Your RxSight, Inc. (NASDAQ:RXST) Investment? Contact BFA Law before the September 22 Legal Deadline

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against RxSight, Inc. (NASDAQ: RXST) and certain of the Compa...

5 weeks ago - GlobeNewsWire

RXST COURT NOTICE: RxSight, Inc. Investors may have been Affected by Fraud -- Contact BFA Law before September 22 if You Suffered Losses (NASDAQ:RXST)

NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against RxSight, Inc. (NASDAQ: RXST) and certain of the Compa...

5 weeks ago - GlobeNewsWire

RxSight, Inc. (RXST) Q2 2025 Earnings Call Transcript

RxSight, Inc. (NASDAQ:RXST) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Oliver Moravcevic - Vice President of Investor Relations Ronald M. Kurtz - Co-President, CE...

5 weeks ago - Seeking Alpha

RxSight, Inc. Reports Second Quarter 2025 Financial Results

ALISO VIEJO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following ...

5 weeks ago - GlobeNewsWire

RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors

ALISO VIEJO, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following ...

6 weeks ago - GlobeNewsWire

RXST INVESTORS: RxSight, Inc. (NASDAQ:RXST) Investors may have been Affected by Fraud – Contact BFA Law by September 22 about Potentially Recovering Losses

NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against RxSight, Inc. (NASDAQ: RXST) and certain of the Compa...

7 weeks ago - GlobeNewsWire

RXST LAWSUIT: RxSight, Inc. Sued for Fraud after LDD Sales Plummet – Contact BFA Law by September 22 Court Deadline (NASDAQ:RXST)

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against RxSight, Inc. (NASDAQ: RXST) and certain of the Compa...

7 weeks ago - GlobeNewsWire

Berger Montague PC Investigates Securities Claims Against RxSight, Inc. (NASDAQ: RXST)

PHILADELPHIA , July 25, 2025 /PRNewswire/ -- Berger Montague PC , a national securities litigation law firm announces it is investigating potential securities fraud claims involving RxSight, Inc. ("Rx...

7 weeks ago - PRNewsWire

RxSight, Inc. Investors: Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses ​

2 months ago - GlobeNewsWire

RXSIGHT, INC. (NASDAQ: RXST) INVESTOR ALERT Investors With Large Losses in RxSight Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquir...

2 months ago - GlobeNewsWire

RxSight, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – RXST

LOS ANGELES--(BUSINESS WIRE)---- $RXST--RxSight, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – RXST.

2 months ago - Business Wire